Post by Thermo Fisher Scientific

From the exhibit hall to conversations with customers and partners, BIO International 2026 has been filled with ideas, collaboration and a shared focus on accelerating the future of drug development. This week in San Diego, we've been discussing how AI, connected scientific data and advanced manufacturing are helping researchers and drug developers work more efficiently, make more informed decisions and bring new therapies to patients faster. A key theme across many conversations is the growing role of AI in scientific discovery. As announced this week by NVIDIA, Thermo Fisher Scientific is among the companies helping bring AI into the laboratory through BioNeMo skills, building on leadership across scientific instruments, equipment, consumables and services for the life sciences. Together with our collaborations across the scientific ecosystem, these efforts are helping customers automate workflows, connect data and generate deeper insights across research and development. We're grateful for the opportunity to connect with innovators from across the biotech and pharmaceutical community who are working to solve some of healthcare's most complex challenges. Thank you to everyone who has stopped by our booth, shared perspectives and explored new possibilities with us. Together, we're helping advance the science that moves therapies from discovery to patients.